#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rosai-Dorfman syndrome Adrenogenital syndrome Retinitis pigmentosa Non-Hodgkin's lymphoma Osteogenesis imperfecta Anaemia Progressive supranuclear palsy Pneumonia Factor IX deficiency Proteus syndrome Herpes simplex Myotonia Anti-glomerular basement membrane disease Cerebellar ataxia Erythema More trials…

    Learn about Rare Diseases

    Sjogren’s syndrome – Basic Information Pelizaeus-Merzbacher disease – Treatment Chordoma – Trials in Disease Antisynthetase syndrome – Treatment Lymphatic malformation – Basic Information Mucopolysaccharidosis II – Treatment Crigler-Najjar syndrome – Treatment Breast angiosarcoma – Basic Information Progressive multifocal leukoencephalopathy – Treatment Methylmalonic acidaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tovorafenib Nilotinib Deoxyribonucleic Acid COLESEVELAM HYDROCHLORIDE Fipaxalparant Fluorouracil Calcitriol Magnesium Chloride Diphenhydramine Eltrombopag Teriparatide Siltuximab Sonelokimab Protease Interleukin-2 Aticaprant Oxymetazoline Hydrochloride Indapamide MB-HUCART19.1 Cetrimide More therapies…

    Learn about Your Condition

    Irritable bowel syndrome Dent's disease Immune thrombocytopenia Dystonia Coma Pyoderma Bone marrow failure Thalassaemia Biliary adenoma Peritoneal abscess Encephalitis Japanese B Ovarian cancer Hyperparathyroidism primary Melanoma recurrent Neurofibromatosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Università degli studi Gabriele D’Annunzio Chieti-Pescara…

Università degli studi Gabriele D’Annunzio Chieti-Pescara Centro di Studi e tecnologie avanzate

Via Luigi Polacchi 11, Chieti, 66100, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Embolism venous
    • Gastrointestinal cancer metastatic
    Investigated Drugs:
    • Abelacimab
    • Dalteparin Sodium
    Austria Czechia France Germany Hungary Ireland +6

  • Study on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Sonelokimab
    Austria Bulgaria Germany Hungary Italy Norway +2

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Not recruiting

    4 1
    Investigated Drugs:
    • Bhv-7000
    Denmark Finland Germany Greece Hungary Italy +5

  • Study on Capecitabine and Oxaliplatin for Patients with High Risk Rectal Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    Italy

  • Study on BHV-7000 for Patients with Generalized Tonic-clonic Seizures in Idiopathic Generalized Epilepsy

    Not recruiting

    4 1
    Investigated Diseases:
    • Idiopathic generalised epilepsy
    Investigated Drugs:
    • Bhv-7000
    Austria Belgium Croatia Finland France Germany +5

  • Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Nivolumab
    • Rucaparib
    Belgium Czechia Denmark Germany Greece Ireland +5

  • Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Diphenhydramine Hydrochloride
    • Methylprednisolone
    • Ocrelizumab
    Belgium Denmark France Germany Greece Hungary +4

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Kappa Monoclonal Antibody Against Interleukin 18
    Bulgaria Czechia France Germany Greece Italy +2

  • Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Evolocumab
    Austria Belgium Bulgaria Czechia Denmark Estonia +16
Previous Page
1 … 4 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!